期刊文献+

复发性卵巢交界性肿瘤保留生育功能手术的临床疗效观察 被引量:3

The results of fertility conservative surgery for recurrent borderline ovarian tumors
下载PDF
导出
摘要 目的:了解复发性卵巢交界性肿瘤患者施行保留生育功能手术后的月经、生育功能以及肿瘤复发情况。方法:回顾分析2000至2006年浙江大学附属妇产科医院收治的复发性卵巢交界性肿瘤6例患者施行保留生育功能手术后的月经、生育以及复发情况。结果:(1)6例患者中5例月经正常;(2)3例患者共妊娠4次,其中3次为足月妊娠并分娩活婴,1次流产,自然妊娠率达50%;(3)平均随访时间为32个月(6~72个月),其中1例复发,但未发生与肿瘤相关的死亡。结论:对年轻有强烈生育要求的复发性卵巢交界性肿瘤患者仍可考虑施行保留生育功能手术,术后自然妊娠率高,但需严密随访。 Objective:To evaluate the menstruate, fertility and recurrence results of fertility conservative surgery for women with recurrent borderline ovarian tumors. Methods:Six pa- tients with recurrent borderline ovarian tumors who had conservative surgery from 2000 to 2006 were identified from Women's hospital, Zhejiang University. Results: (1) In the six women, five patients had normal menstrual function. (2) Three women had successful pregnancies, with a total of 3 live births and 1 abortion. The spontaneous pregnancy rate was 50%. (3) The mean duration of follow-up was 32 months( range ,6 -72). One of the six patients with recurrent borderline ovarian tumors developed recurrence once more. But no disease related deaths occurred. Conclusion: The second conservative surgery for patients with recurrent borderline ovarian tumors should still be considered for women who are young and desire preservation of fertility. The spontaneous pregnancy rate is satisfactory. However, careful follow-up is needed to detect recurrent disease.
出处 《现代妇产科进展》 CSCD 北大核心 2008年第1期16-18,共3页 Progress in Obstetrics and Gynecology
关键词 卵巢交界性肿瘤 复发 生育力 Borderline ovarian tumors Recurrence Fertility
  • 相关文献

参考文献13

  • 1Gershenson DM. Clinical management potential tumors of low malignancy [ J ]. Best Pract Res Clin Obstet Gynaecol, 2002,16:513-527
  • 2Morice P, Camatte S, El Hassan J, et al. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors [ J ]. Fertil Steril,2001,75 :92-96
  • 3Gotlieb WH,Flikker S,Davidson B,et al. Borderline tumors of the ovary :fertility treatment ,conservative management ,and pregnancy outcome [ J ]. Cancer, 1998,82:141-146
  • 4Boran N ,Cil BA ,Tulunay G,et al. Fertility and recurrence results of conservative surgery for borderline ovarian tumors [ J ]. Gynecol Oncol, 2005,97 : 845-851
  • 5Donnez J, Munschke A, Bediere M, et al. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary[ J]. Fertil Steril,2003,79 : 1216-1221
  • 6Zanetta G, Rota S, Chiari S, et al. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma:a prospective study [ J]. J Clin Oncol,2001,19:2658-2664
  • 7Morris RT,Gershenson DM,Silva EG,et al.Outcome and reproductive function after conservative surgery for borderline ovarian tumors [ J ]. Obstet Gynecol,2000,95:541-547
  • 8Fauvet R,Poncelet C,Boccara J,et al. Fertility after conservative treatment for borderline ovarian tumours: a French multicenter study [ J ]. Fertil Steril,2005 ,83 :284-290
  • 9Tourgeman D, Lu J J, Boostanfar R, et al. Human chorionic gonadotropin suppresses ovarian epithelial neoplastic cell proliferation in vitro [ J ]. Fertil Steril, 2002,78 : 1096- 1099
  • 10Fauvet R, Boccara J, Dufournet C, et al. Restaging surgery for women with borderline ovarian tumors : results of a French multicenter study [ J ]. Cancer, 2004, 100: 1145-1151

同被引文献37

  • 1郭丽娜,连利娟.卵巢浆液性交界瘤高危病例的病理特点[J].生殖医学杂志,2004,13(3):179-181. 被引量:6
  • 2Jones MB.Borderline ovarian tumors;current concepts for prognostic factors and clinical management[J].Clin Obstet Gynecol,2006,49(3):517-525.
  • 3Link CJ Jr,Kohn E,Reed E.The relationship between borderlineovarian tumors and epithelial ovarian carcinoma;epidemiologic,pathologic,and molecular aspects[J].Gynecol Oncol,1996,60(3):347-354.
  • 4Pium B,Rabinovich A,Yanai-Inbar 1.Three primary malignancies related to BRCA mutation successively occurring in a BRCAI 185delAG mutation tamer[J].Eur J Obstet Gynecol Reprod Biol,2001,97(2):241-244.
  • 5Helou K,Padilla-Hash H,Wangsa D,et al.Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumors[J].Cancer Genet Cytogenet,2006,170(1):1-8.
  • 6Gotlieb WH,Chetrit A,Menczer J,et al.Demographic and genetic characteristics of patients with borderline ovarian tumors as compared to early stage invasive ovarian cancer[J].Gynecol Oncot,2005,97(3):780-783.
  • 7Sijmons EA,van Lankveld MA,Witteveen PO,et al.Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome[J].Eur J Obstet Gynecol Reprod Biol,2007,131(2):203-208.
  • 8Tempfer CB,Poltersuer S,Bentz EK,et al.Accuracy of intraoperative frozen section analysis in borderline tumors of the ovary:A retrospective analysis of 96 cases and review of the literature[J].Gynecol Oncol,2007,107(2):248-252.
  • 9Kim K,Chung HH,Kim JW,et al.Clinical impact of under-diagnosis by frozen section examination is minimal in borderline ovarian tumors,.Eur J Sorg Oncol,2009,35(9):969-973.
  • 10Webb PM,Purdie DM,Graver S,et al.Symptoms and diagnosis of borderline,early and advanced epithelial ovarian cancer[J] Gynecol Oncol,2004,92(l):232-239.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部